Power Life Sciences Inc.
Clinical study participation has historically been heavily biased toward specific demographics. This study will invite several participants to gather a wide range of information on clinical trial experiences for migraine patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of migraine. People with migraine who are invited to take part in medical research will benefit from the analysis of the data.
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||An In Depth Study Examining Patterns in the Clinical Trial Experiences of Migraine Patients|
|Actual Study Start Date :||January 28, 2023|
|Estimated Primary Completion Date :||January 28, 2024|
|Estimated Study Completion Date :||January 28, 2025|
Information not available for Arms and Intervention/treatment
|Ages Eligible for Study:||18 Years to 65 Years|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.